APAC Stem Cell Therapy Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	153 Pages	Data Bridge Market Research	May, 2022	DAABD17330409

Best Price Guarantee
Price	from $3,500
Length	153 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2022
SKU	DAABD17330409

APAC Stem Cell Therapy Market - Industry Trends and Forecast to 2029

The Asia-Pacific stem cell therapy market is projected to register a substantial CAGR of 10.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029

Market Segmentation:
Asia-Pacific Stem Cell Therapy Market, Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors), Country (South Korea, Japan, and India) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Asia-Pacific stem cell therapy market are:
• Rise in investment in research and development
• Rise in prevalence of chronic diseases

Market Players

Some of the major players operating in the Asia-Pacific stem cell therapy market are:
• JCR Pharmaceuticals Co., Ltd
• MEDIPOST
• Takeda Pharmaceutical Company Limited
• CORESTEM, Inc.
• PHARMICELL Co., Ltd.
• STEMPEUTICS RESEARCH PVT LTD
• ANTEROGEN.CO., LTD
• U.S. Stem Cell, Inc.
• Mesoblast Ltd
• Orthofic Medical Inc.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia Pacific Stem Cell Therapy Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Asia Pacific Stem Cell Therapy Market: Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Product Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Pestel; 4.2 Porter's Five Forces Model
5 Epidemiology
6 Pipeline Analysis For The Asia Pacific Stem Cell Therapy Market
7 Asia Pacific Stem Cell Therapy Market: Regulations
8 Market Overview: 8.1 Drivers; 8.1.1 The Rise In Prevalence And Incidence Of Chronic Diseases; 8.1.2 Rise In Investment In Research And Development And Availability Of Funding For Stem Cell Research; 8.1.3 Growing Biotechnology Sector; 8.1.4 Rise In Gmp Certification Approvals For Cell Therapy Production Facilities; 8.1.5 Rise In Clinical Trials For Stem-cell-based Therapies; 8.2 Restraints; 8.2.1 The Rise In Cost Of Stem-cell-based Therapy Research; 8.2.2 The Risks Faced While Undergoing Stem Cell Therapy; 8.2.3 Ethical Concerns Related To Stem Cell Therapy Research; 8.2.4 Availability Of Alternatives; 8.3 Opportunities; 8.3.1 Strategic Initiative By Market Players; 8.3.2 Rise In Healthcare Expenditure; 8.3.3 The Emergence Of Induced Pluripotent Stem Cells (Ipscs); 8.4 Challenges; 8.4.1 The Lack Of Skilled Professionals Required For Stem Cell Therapy; 8.4.2 Stringent Regulations
9 Asia Pacific Stem Cell Therapy Market, By Product Type: 9.1 Overview; 9.2 Bone Marrow Derived Mesenchymal Stem Cells; 9.3 Placental/Umbilical Stem Cell; 9.4 Adipose Tissue Derived Mesenchymal Stem Cells; 9.5 Others
10 Asia Pacific Stem Cell Therapy Market, By Type: 10.1 Overview; 10.2 Allogeneic Stem Cell Therapy; 10.2.1 Musculoskeletal Disorders; 10.2.2 Wounds And Injuries; 10.2.3 Acute Graft-versus-host Disease (Agvhd); 10.2.4 Surgeries; 10.2.5 Gastrointestinal Diseases; 10.2.6 Other Application; 10.3 Autologous Stem Cell Therapy; 10.3.1 Cardiovascular Diseases; 10.3.2 Gastrointestinal Diseases; 10.3.3 Other Application
11 Asia Pacific Stem Cell Therapy Market, By Application: 11.1 Overview; 11.2 Musculoskeletal Disorders; 11.3 Wounds And Injuries; 11.4 Acute Graft-versus-host Disease (Agvhd); 11.5 Surgeries; 11.6 Gastrointestinal Diseases; 11.7 Cardiovascular Diseases; 11.8 Other Application
12 Asia Pacific Stem Cell Therapy Market, By End User: 12.1 Overview; 12.2 Hospital And Surgical Centers; 12.3 Therapeutic Companies; 12.4 Services Companies; 12.5 Others
13 Asia Pacific Stem Cell Therapy Market, By Distribution Channel: 13.1 Overview; 13.2 Direct Tender; 13.3 Third Party Distributors
14 Asia Pacific Stem Cell Therapy Market, By Region: 14.1 Asia-pacific; 14.1.1 South Korea; 14.1.2 Japan; 14.1.3 India
15 Asia Pacific Stem Cell Therapy Market: Company Landscape: 15.1 Company Share Analysis: Asia Pacific
16 Swot Analysis
17 Company Profile: 17.1 Osiris Therapeutics, Inc. (A Subsidiary Of Smith+Nephew) (2021); 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Development; 17.2 Jcr Pharmaceuticals Co., Ltd ( (2021); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Developments; 17.3 Orthofix Medical Inc. (2021); 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Developments; 17.4 Medipost (2021); 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Developments; 17.5 Takeda Pharmaceutical Company Limited (2021); 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Company Share Analysis; 17.5.4 Product Portfolio; 17.5.5 Recent Development; 17.6 Corestem, Inc. (2021); 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Pharmicell Co., Ltd. (2021); 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Developments; 17.8 Anterogen.Co., Ltd (2021); 17.8.1 Company Snapshot; 17.8.2 Product Portfolio; 17.8.3 Recent Developments; 17.9 Athersys, Inc.(2021); 17.9.1 Company Snapshot; 17.9.2 Revenue Analysis; 17.9.3 Product Portfolio; 17.9.4 Recent Developments; 17.10 Brainstorm Cell Limited (2021); 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Developments; 17.11 Biorestorative Therapies, Inc. (2021); 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Developments; 17.12 Holostem Terapie Avanzate S.R.L. (2021); 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Developments; 17.13 International Stemcell Corporation (2021); 17.13.1 Company Snapshot; 17.13.2 Revenue Analysis; 17.13.3 Product Portfolio; 17.13.4 Recent Development; 17.14 Mesoblast Ltd (2021); 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Developments; 17.15 Pluristem Inc.(2021); 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Stempeutics Research Pvt Ltd; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Developments; 17.17 U.S. Stem Cell, Inc. (2021); 17.17.1 Company Snapshot; 17.17.2 Revenue Analysis; 17.17.3 Product Portfolio; 17.17.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Asia Pacific Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 2 Asia Pacific Bone Marrow Derived Mesenchymal Stem Cells In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 3 Asia Pacific Placental/Umbilical Stem Cell In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 4 Asia Pacific Adipose Tissue Derived Mesenchymal Stem Cells In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 5 Asia Pacific Others In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 6 Asia Pacific Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 7 Asia Pacific Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 8 Asia Pacific Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 9 Asia Pacific Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 10 Asia Pacific Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 11 Asia Pacific Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 12 Asia Pacific Musculoskeletal Disorders In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 13 Asia Pacific Wounds And Injuries In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 14 Asia Pacific Acute Graft-versus-host Disease (Agvhd) In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 15 Asia Pacific Surgeries In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 16 Asia Pacific Gastrointestinal Diseases In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 17 Asia Pacific Cardiovascular Diseases In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 18 Asia Pacific Other Application In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 19 Asia Pacific Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 20 Asia Pacific Hospital And Surgical Centers In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 21 Asia Pacific Therapeutic Companies In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 22 Asia Pacific Services Companies In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 23 Asia Pacific Others In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 24 Asia Pacific Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 25 Asia Pacific Direct Tender In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 26 Asia Pacific Third Party Distributors In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 27 Sia-pacific Stem Cell Therapy Market, By Country, 2020-2029 (Usd Million); Table 28 Asia-pacific Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 29 Asia-pacific Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 30 Asia-pacific Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 31 Asia-pacific Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 32 Asia-pacific Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 33 Asia-pacific Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 34 Asia-pacific Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 35 South Korea Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 36 South Korea Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 37 South Korea Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 38 South Korea Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 39 South Korea Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 40 South Korea Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 41 South Korea Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 42 Japan Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 43 Japan Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 44 Japan Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 45 Japan Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 46 Japan Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 47 Japan Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 48 Japan Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 49 India Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 50 India Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 51 India Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 52 India Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 53 India Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 54 India Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 55 India Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 Asia Pacific Stem Cell Therapy Market : Segmentation; Figure 2 Asia Pacific Stem Cell Therapy Market: Data Triangulation; Figure 3 Asia Pacific Stem Cell Therapy Market: Droc Analysis; Figure 4 Asia Pacific Stem Cell Therapy Market: Asia Pacific Vs Regional Market Analysis; Figure 5 Asia Pacific Stem Cell Therapy Market: Company Research Analysis; Figure 6 Asia Pacific Stem Cell Therapy Market: Interview Demographics; Figure 7 Asia Pacific Stem Cell Therapy Market: Dbmr Position Grid; Figure 8 Asia Pacific Stem Cell Therapy Market: Vendor Share Analysis; Figure 9 Asia Pacific Stem Cell Therapy Market: End User Coverage Grid; Figure 10 Asia Pacific Stem Cell Therapy Market: Segmentation; Figure 11 North America Is Anticipated To Dominate The Asia Pacific Stem Cell Therapy Market And Asia-pacific Is Estimated To Be Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 12 Increased Incidence Of Chronic Diseases, Rise In Clinical Trials, Gmp Certification And Product Appprovals Is Expected To Drive The Asia Pacific Stem Cell Therapy Market From 2022 To 2029; Figure 13 Product Type Segment Is Expected To Have The Largest Share Of The Asia Pacific Stem Cell Therapy Market From 2022 & 2029; Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Stem Cell Therapy Market; Figure 15 Number And Ages Of People 65 Or Older With Alzheimer's Dementia In 2022; Figure 16 Incidence Of Various Types Of Cancer In 2020; Figure 17 Asia Pacific Stem Cell Therapy Market: By Product Type, 2021; Figure 18 Asia Pacific Stem Cell Therapy Market: By Product Type, 2022-2029 (Usd Million); Figure 19 Asia Pacific Stem Cell Therapy Market: By Product Type, Cagr (2022-2029); Figure 20 Asia Pacific Stem Cell Therapy Market: By Product Type, Lifeline Curve; Figure 21 Asia Pacific Stem Cell Therapy Market: By Type, 2021; Figure 22 Asia Pacific Stem Cell Therapy Market: By Type, 2022-2029 (Usd Million); Figure 23 Asia Pacific Stem Cell Therapy Market: By Type, Cagr (2022-2029); Figure 24 Asia Pacific Stem Cell Therapy Market: By Type, Lifeline Curve; Figure 25 Asia Pacific Stem Cell Therapy Market: By Application, 2021; Figure 26 Asia Pacific Stem Cell Therapy Market: By Application, 2022-2029 (Usd Million); Figure 27 Asia Pacific Stem Cell Therapy Market: By Application, Cagr (2022-2029); Figure 28 Asia Pacific Stem Cell Therapy Market: By Application, Lifeline Curve; Figure 29 Asia Pacific Stem Cell Therapy Market: By End User, 2021; Figure 30 Asia Pacific Stem Cell Therapy Market: By End User, 2022-2029 (Usd Million); Figure 31 Asia Pacific Stem Cell Therapy Market: By End User, Cagr (2022-2029); Figure 32 Asia Pacific Stem Cell Therapy Market: By End User, Lifeline Curve; Figure 33 Asia Pacific Stem Cell Therapy Market: By Distribution Channel, 2021; Figure 34 Asia Pacific Stem Cell Therapy Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 35 Asia Pacific Stem Cell Therapy Market: By Distribution Channel, Cagr (2022-2029); Figure 36 Asia Pacific Stem Cell Therapy Market: By Distribution Channel, Lifeline Curve; Figure 37 Asia-pacific Stem Cell Therapy Market: Snapshot (2021); Figure 38 Asia-pacific Stem Cell Therapy Market: By Country (2021); Figure 39 Asia-pacific Stem Cell Therapy Market: By Country (2022 & 2029); Figure 40 Asia-pacific Stem Cell Therapy Market: By Country (2021 & 2029); Figure 41 Asia-pacific Stem Cell Therapy Market: By Product Type (2022 & 2029); Figure 42 Asia Pacific Stem Cell Therapy Market: Company Share 2021 (%)